Evidence map›Paper›PMID 25731661›Full record

ArticleAIDS and behavior2016

Providing ART to HIV Seropositive Persons Who Use Drugs: Progress in New York City, Prospects for "Ending the Epidemic".

Don C Des Jarlais, Kamyar Arasteh, Courtney McKnight, Jonathan Feelemyer, Holly Hagan, Hannah L F Cooper, Aimee N C Campbell, Susan Tross, David C Perlman

Abstract read
In one paragraph

Article in AIDS and behavior, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Don C Des JarlaisBaron Edmond de Rothschild Chemical Dependency Institute, Mount Sinai Beth Israel, 160 Water Street FL 24, New York, NY, 10038, USA. ddesjarlais@chpnet.org.
Kamyar ArastehBaron Edmond de Rothschild Chemical Dependency Institute, Mount Sinai Beth Israel, 160 Water Street FL 24, New York, NY, 10038, USA.
Courtney McKnightBaron Edmond de Rothschild Chemical Dependency Institute, Mount Sinai Beth Israel, 160 Water Street FL 24, New York, NY, 10038, USA.
Jonathan FeelemyerBaron Edmond de Rothschild Chemical Dependency Institute, Mount Sinai Beth Israel, 160 Water Street FL 24, New York, NY, 10038, USA.
Holly HaganCollege of Nursing, New York University, New York, NY, USA.
Hannah L F CooperDepartment of Behavioral Sciences and Health Education, Rolling School of Public Health, Emory University, Atlanta, GA, USA.
Aimee N C CampbellDepartment of Psychiatry, Columbia University, New York, NY, USA.
Susan TrossDepartment of Psychiatry, Columbia University, New York, NY, USA.
David C PerlmanBaron Edmond de Rothschild Chemical Dependency Institute, Mount Sinai Beth Israel, 160 Water Street FL 24, New York, NY, 10038, USA.
Mount Sinai Beth Israel · USColumbia University · USEmory University · USNew York University · US

Funding

The Statistics, Data Science, and Data Management (SDM) CoreP30MH043520 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI MILTON L WAINBERG · 2003 to 2026
$48.2M
Transdisciplinary Theoretical Svnthesis and Development CoreP30DA011041 · NIDA · NEW YORK UNIVERSITY · PI Holly Hagan · 1998 to 2026
$38.9M
Risk Factors for HIV/AIDS in Drug UsersR01DA003574 · NIDA · NEW YORK UNIVERSITY · PI DES JARLAIS, DON C, MCKNIGHT, COURTNEY · 1986 to 2025
$16.2M
Evaluating ART for All HIV Seropositives: Can it work with the hardest cases?R01DA035707 · NIDA · ST. LUKE'S-ROOSEVELT INST FOR HLTH SCIS · PI CAMPBELL, AIMEE N, DES JARLAIS, DON C · 2013 to 2017
$3.1M
NIDA NIH HHS 1R01DA0356707-01NIDA NIH HHS 5R01DA003574NIDA NIH HHS P30 DA011041NIDA NIH HHS R01 DA003574NIDA NIH HHS R01 DA035707NIMH NIH HHS P30 MH043520
6 · The paper itself

Abstract

New York City has experienced the largest HIV epidemic among persons who use psychoactive drugs. We examined progress in placing HIV seropositive persons who inject drugs (PWID) and HIV seropositive non-injecting drug users (NIDU) onto antiretroviral treatment (ART) in New York City over the last 15 years. We recruited 3511 PWID and 3543 NIDU from persons voluntarily entering drug detoxification and methadone maintenance treatment programs in New York City from 2001 to 2014. HIV prevalence declined significantly among both PWID and NIDU. The percentage who reported receiving ART increased significantly, from approximately 50 % (2001-2005) to approximately 75 % (2012-2014). There were no racial/ethnic disparities in the percentages of HIV seropositive persons who were on ART. Continued improvement in ART uptake and TasP and maintenance of other prevention and care services should lead to an "End of the AIDS Epidemic" for persons who use heroin and cocaine in New York City.

Indexed as

AdultAIDS SerodiagnosisAnti-Retroviral AgentsDrug UsersEthnicityFemaleHealth SurveysHIV InfectionsHIV SeroprevalenceHumansLogistic ModelsMaleMiddle AgedMultivariate AnalysisNew York CityPrevalenceAnti-Retroviral AgentsAntiretroviral therapyHIVNon-injection drug usersPersons who inject drugsTreatment as prevention

Identifiers

PMID25731661
PMCPMC4559487
OpenAlexW2009414228

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.